You searched for Antibody candidate - Page 55 of 69

News and Trends 12 Jul 2016

Which European Biotechs made it to the Billion-Euro Club in 2016?

…time) Founded: 1992 City: Munich (Germany) Mission: MorphoSys is a biopharmaceutical company with a rich pipeline of future therapeutic antibody products and a sustainable dual therapeutic business model. Comment: It’s…

July 12, 2016 - 6 minutesmins - By Philip Hemme

News and Trends 20 Feb 2018

Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

Phase I results show promise for a new treatment for atopic dermatitis that may become a strong competitor to the market leader, Humira. Morphosys and Galapagos are developing an antibody…

February 20, 2018 - 3 minutesmins - By Alexander Burik

More News! 7 Oct 2019

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

…money to fund the preclinical development of antibody drugs for unspecified autoimmune diseases. The company will also expand its drug discovery efforts to other unspecified disease areas and grow its…

October 7, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 9 Aug 2022

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

…issued two patents that will protect Arecor Therapeutics’ formulations of high-concentration adalimumab until 2038. The company made the announcement today (August 9). Monoclonal antibody Adalimumab, sold by AbbVie under the…

August 9, 2022 - 3 minutesmins - By Liza Laws

News and Trends 2 Dec 2016

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

…(BDCs) outperform ADCs? Bicycle Therapeutics is a company in Cambridge founded by one of the top biotech leaders in the UK’s golden triangle. Its unique technology to develop antibody-like bicyclic…

December 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Jul 2022

Boston startup bags $40M Series A to smash preclinical bottlenecks

…of the startup is a type of drugs called targeted effectors. This class, including cell engagers and antibody-drug conjugates, involves attaching a therapeutic payload onto a carrier molecule that delivers…

July 14, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Mar 2023

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

…next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and…

March 14, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 4 Sep 2024

2024: a year of breakthroughs for endometrial cancer?

…Rochester OKN-007 – Oblato, Inc ADCs: new treatments see encouraging results in clinic Another advancement in endometrial cancer research is the development of antibody drug conjugates (ADCs) that are “designed…

September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter

antibody drug conjugate adc small cancer treatment

News and Trends 14 Apr 2023

TORL BioTherapeutics launches with $158M to target cancer

…pipeline of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) were discovered in the laboratory of scientific co-founder Dennis Slamon, professor of medicine, and chief of the division of hematology/oncology at…

April 14, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax

…broader coverage against prevalent pneumococcal variants and potentially creates higher immune responses than current vaccines. Affinivax’s most advanced vaccine candidate (AFX3772) includes 24 pneumococcal polysaccharides plus two conserved pneumococcal proteins…

June 1, 2022 - 3 minutesmins - By Jim Cornall

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

…two companies agreed to a research and licensing agreement to develop up to 15 small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples….

November 2, 2023 - 8 minutesmins - By Willow Shah-Neville

autoimmune disease enzyme hansa medical 1

News and Trends 19 Feb 2018

The FDA Backs a Bacterial Enzyme to Treat a Rare Autoimmune Disease

The FDA has awarded Hansa Medical’s lead candidate for the treatment of an autoimmune disease with Orphan Drug Designation, which will support its journey through clinical development. Swedish biotech, Hansa…

February 19, 2018 - 2 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Which European Biotechs made it to the Billion-Euro Club in 2016?

Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

Boston startup bags $40M Series A to smash preclinical bottlenecks

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

2024: a year of breakthroughs for endometrial cancer?

TORL BioTherapeutics launches with $158M to target cancer

GSK to acquire clinical-stage biopharmaceutical company Affinivax

How French pharma giant Sanofi is betting big on AI

The FDA Backs a Bacterial Enzyme to Treat a Rare Autoimmune Disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!